Transcription factors of the basic-helix-loop-helix (bHLH) family are implicated in the regulation of differentiation in a wide variety of cell types, including trophoblast cells (10) , pigment cells (31) , B cells (29, 42) , chondrocytes and osteoblasts (11, 33) , and cardiac muscle cells (8, 15) . Perhaps the most extensively studied subfamilies of bHLH proteins are those that regulate myogenesis and neurogenesis. The myogenic bHLH factors, (MyoD, myogenin, Myf5, and MRF4), appear to have unique as well as redundant functions during myogenesis (37, 39) . It is thought that either Myf5 or MyoD is necessary to determine myogenic fate, whereas, myogenin is necessary for events involved in terminal differentiation (14, 24, 28, 36) . Recent work on neurogenic bHLH proteins suggests parallels between the myogenic and neurogenic subfamilies of bHLH proteins. Genes of the Drosophila melanogaster achaetescute complex and the atonal gene have been shown to be involved in neural cell fate determination (2, 9, 17) , and the mammalian homologs MASH1 and MATH1 are expressed in the neural tube at the time of neurogenesis (1, 22) . Two related vertebrate bHLH proteins, neuroD and NEX-1/MATH-2, are expressed slightly later in central nervous system development, predominantly in the marginal layer of the neural tube and persisting in the mature nervous system (6, 21, 30) . neuroD was also cloned as a factor that regulates insulin transcription in pancreatic beta cells and was named Beta2 (25) . Constitutive expression of neuroD in developing Xenopus embryos produces ectopic neurogenesis in the ectodermal cells, indicating that neuroD is capable of regulating a neurogenic program. A neuroD homolog has been identified in Caenorhabditis elegans (21) , suggesting that this molecular mechanism of regulating neurogenesis may be conserved between vertebrates and invertebrates.
We have isolated two novel genes related to neuroD: neuroD2 and neuroD3. Similar to MATH1, the expression of neuroD3 peaks during embryonic development and is not detected in the mature nervous system. neuroD2 shows a high degree of sequence similarity to both neuroD and NEX-1/MATH2 and is similarly expressed both during embryogenesis and in the mature nervous system, demonstrating an expression pattern that partially overlaps that of neuroD. Like neuroD, neuroD2 expression in Xenopus embryos induces neurogenesis in ectodermal cells. Transfection of expression vectors for neuroD and neuroD2 indicates that these highly similar transcription factors demonstrate some target specificity, with the GAP-43 promoter activated by neuroD2 and not by neuroD. The partially overlapping expression pattern and target specificity of neuroD and neuroD2 suggest that this group of neurogenic transcription factors may contribute to the establishment of neuronal identity in the nervous system by acting on an overlapping but noncongruent set of target genes.
MATERIALS AND METHODS
Library screening. The human neuroD2 and neuroD3 genes were cloned from a genomic library in lambda FIX II made from human fibroblasts (Stratagene). LE392 cells were infected and plated in top agar to yield approximately 10 6 colonies on 20 15-cm-diameter plates. The plates were overlaid with Hybond filters, which were then dried, denatured in 0.5 M NaOH-1.5 M NaCl, neutralized in 1.5 M NaCl-0.5 M Tris (pH 7.2), and then cross-linked with UV. Membranes were probed with a 1-kb fragment from the murine neuroD1 cDNA (22) HPO 4 , and 1 mM EDTA; pH 7.7]) at 65ЊC for 10 min and hybridized in FBI buffer with 10 g of denatured salmon sperm DNA per ml and probe at (0.25 to 0.5) ϫ 10 7 cpm/ml at 65ЊC for 8 to 12 h. Membranes were washed at a final stringency of 0.1ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS at 55ЊC. To clone the mouse neuroD2 and neuroD3 genes, a similar protocol was used to screen a 129Sv mouse genomic library (provided by Glenn Friedrich) cloned in lambda-Dash II (Stratagene). To clone the mouse neuroD2 cDNA, a cDNA library made from 16-day mouse embryos in the lambda-SH/lox (Novagen) vector was screened. Attempts to clone the mouse neuroD3 cDNA from this library were not successful.
RNA preparation and Northern (RNA) blot analysis. Total RNA was isolated from whole mouse embryos, adult mouse tissues, and P19 cells with RNazol B according to the protocol provided (Cinna/Biotecx CS-105B). RNA was size fractionated on 1.5% agarose gels and transferred to Hybond-N membranes. Hybridization was carried out in 7% SDS-0.25 M Na 2 PO 4 -10 mg of bovine serum albumin per ml-1 mM EDTA at 65ЊC for at least 5 h and then washed in 0.1ϫ SSC-0.1% SDS at 55 to 60ЊC. Northern blots were probed with fragments representing the region 3Ј of the bHLH domain to avoid cross-hybridization between genes. The probe for neuroD1 was made from a 350-bp PstI fragment from the mouse neuroD cDNA (21) that encompasses the region coding for amino acids 187 to 304; the probe for neuroD2 was made from a 635-bp PstI fragment from the mouse neuroD2 cDNA that encompasses the region from amino acid 210 through the 3Ј nontranslated region; and the probe for neuroD3 was made from a 400-bp ApaI-BamHI fragment from the neuroD3 genomic region that is 3Ј prime to the region coding for the bHLH domain.
In situ hybridization. Probes for in situ hybridization were made from the mouse neuroD1 and neuroD2 cDNA fragments used for the Northern blotting with T3-and T7-generated transcripts for sense and antisense probes, incorporating 35 S-UTP label. Frozen 4-to 5-m sagittal sections of adult mouse brain were cut, placed on Fisher Superfrost slides, and frozen at Ϫ80ЊC. Hybridization to 35 S-UTP-labeled probes and autoradiography were performed according to the method of Masters et al. (23) .
Expression vectors. Expression vectors were made in pCS2ϩ or pCS2ϩMT (35) , both of which contain the simian cytomegalovirus promoter, and MT contains six copies of the myc epitope recognized by the 9e10 monoclonal antibody (ATCC CRL1729) cloned in frame upstream of the insert. The 1.75-kb full-length human neuroD1 cDNA (32) from plasmid phcnd1-17a was cloned into the EcoRI site to make pCS2-hND1-17s (hereafter referred to as pCS2-hND1). The 1.53-kb genomic region containing the entire coding sequence of the human neuroD2 gene was cloned into the StuI-XbaI site to make pCS2-hND2-14B1 (hereafter referred to as pCS2-hND2). The mouse 1.95-kb neuroD2 cDNA was cloned into the EcoRI-XhoI sites to make pCS2-mND2-1.1.1 (hereafter referred to as pCS2-mND2). For the myc-tagged construct, a synthetic oligonucleotidemediated mutagenesis was used to introduce an EcoRI site adjacent to the initial ATG codon to result in the myc tag and neuroD2 coding regions being in-frame to make pCS2MT-mND2.
RNA microinjection and analysis of Xenopus laevis embryos. Synthesis of capped RNA for the X. laevis injections was done essentially as described previously (19) with SP6 transcription of pCS2-hND2, pCS2-hND1, and pCS2MT-mND2. The capped RNA was phenol-chloroform extracted, followed by separation of unincorporated nucleotides with a G-50 spin column. Approximately 350 pg of capped RNA was injected into one cell of a two-cell-stage albino X. laevis embryo in a volume of approximately 5 nl, as described previously (35) . Embryos were allowed to develop in 0.1ϫ modified Barth's saline and staged according to the method of Nieuwkoop and Faber (27) . Embryos were fixed in 0.1 M morpholinepropanesulfonic acid (MOPS) (pH 7.4)-2 mM ethylene glycolbis(␤-aminoethyl ether)-N,N,NЈ,NЈ-tetraacetic acid (EGTA)-1 mM MgSO 4 -3.7% formaldehyde for 2 h at room temperature and stored in methanol. Embryos were hydrated through a graded series of methanol-phosphate-buffered saline solutions and prepared for immunohistochemistry as described previously (35) . The embryos were stained with an anti-neural cell adhesion molecule (NCAM) antibody (5) diluted 1:500 (gift of Urs Rutishauser), followed by a goat anti-rabbit alkaline phosphatase-conjugated secondary antibody, or stained with the monoclonal anti-myc tag 9e10 antibody. The presence of the antibody was visualized by nitroblue tetrazolium-5-bromo-4-chloro-3-indolylphosphate toluidinium salt color reaction according to the protocol provided (Gibco).
Tissue culture and transfections. The mouse teratocarcinoma cell line P19 (18) was cultured in minimal essential medium alpha supplemented with 10% fetal bovine serum. Transfections were performed as previously described (34) with an N,N,-bis-(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES)-buffered calcium phosphate precipitation mixture. P19 cells were harvested 48 h after transfection for luciferase and lacZ assays. Expression vectors pCS2-hND1 and pCS2-hND2 are described above. The GAP43 760-bp promoter region driving luciferase in a pGL2 vector modified to contain a poly(A) site upstream of the multiple cloning site was the generous gift of Pate Skene and Joseph Weber. The pND2-luciferase construct was made by cloning a 1-kb fragment of mouse neuroD2 sequence terminating in the first exon cloned into the pGL3 luciferase vector. The p4RTK-luciferase construct was made by placing the 4RTK region from HindIII to XhoI of the p4RTK-CAT vector (38) into the promoterless luciferase vector. Luciferase assays were performed according to methods described in Current Protocols in Molecular Biology (7) .
Nucleotide sequence accession numbers. The GenBank accession numbers for the proteins described here are as follows: human neuroD2, U58681; mouse neuroD2, U58471; human neuroD3, U63842; and mouse neuroD3, U63841.
RESULTS

Predicted protein sequence of neuroD2 and neuroD3.
A human fibroblast genomic library (Stratagene) was screened at moderate stringency with a probe to mouse neuroD for the purpose of isolating the human neuroD gene. In addition to isolating the human neuroD gene (32), six of the genomic clones that were isolated showed a restriction pattern that was distinct from human neuroD, and subsequent sequence analysis demonstrated that the six clones represented two different genes that shared similarity with neuroD in the bHLH region ( Fig. 1 ). We will refer to the original neuroD clone as neuroD1 and the two new clones as neuroD2 and neuroD3.
A fragment of the human neuroD2 gene was used to screen both a mouse genomic library and an embryonic day-16 mouse cDNA library. Five independent cDNAs were mapped by restriction endonucleases and demonstrated identical restriction sites and sequences. Comparison with the corresponding mouse genomic sequence demonstrates that the entire coding region of neuroD2 is contained in the second exon (data not shown). The sequence showed a predicted protein of 382 amino acids that differs from the major open reading frame (ORF) in the human neuroD2 gene at only 9 residues, all in the amino-terminal portion of the protein (Fig. 2 ). neuroD2 has 98% similarity to neuroD1 and MATH2 in the bHLH region and 90% similarity in the 30 amino acids immediately carboxy terminal to the bHLH region (Fig. 2 ). Similar to neuroD1 and MATH2, neuroD2 contains an amino-terminal region rich in glutamate residues that may constitute an acidic activation domain, and has other regions of similarity to neuroD1 throughout the protein (Fig. 2) .
Several attempts to isolate a cDNA for human and mouse neuroD3 were unsuccessful. However, since all identified members of the family of genes related to neuroD1 have their entire coding sequence in a single exon, we determined the major ORF encoded in the genomic DNA from mouse and human neuroD3. The genomic sequence of mouse neuroD3 contains a major ORF of 244 amino acids, and the human neuroD3 gene contains an ORF of 237 amino acids that differs from the predicted mouse protein at 30 positions (Fig. 2) . In contrast to neuroD2, neuroD3 does not contain significant regions of homology to neuroD1 or MATH2/NEX-1 outside of the bHLH region and does not have an amino-terminal region rich in glutamates or acidic amino acids.
Overlapping and separate expression patterns during mouse development. Northern analysis was done to determine in what mouse tissues neuroD2 and neuroD3 were expressed. Fragments from the divergent carboxy-terminal regions of neuroD1 and neuroD2 and the predicted carboxy-terminal region of neuroD3 were used to probe Northern blots containing RNAs prepared from various tissues of newborn (data not shown) and adult (Fig. 3A) mice. Both neuroD1 and neuroD2 VOL. 16, 1996 DIFFERENTIAL ACTIVITIES OF NEUROGENIC bHLH PROTEINS 5793
were detected in the brains of both newborn and adult mice, whereas, neuroD3 was not detected in any of the tissues tested. RNA extracted from dissected regions of the adult mouse nervous system demonstrated that neuroD1 was more abundant in the cerebellum than the cortex, whereas neuroD2 was expressed at relatively equivalent levels in both cerebellum and cortex (Fig. 3B) .
To determine when during mouse embryonic development neuroD2 and neuroD3 were expressed in comparison with neuroD1, RNA was prepared from whole embryos at various developmental stages. As previously reported (21), neuroD1 mRNA was first detected at low levels at embryonic day 9.5 and at increasing levels through embryonic day 12.5, the latest embryonic stage tested (Fig. 3C) . neuroD2 mRNA was first detected at embryonic day 11 ( Fig. 3D ) and also increased in abundance through embryonic day 12.5 ( Fig. 3C) . Although we did not detect neuroD3 in the adult tissues, the embryonic expression pattern showed transient expression between embyronic days 10 and 12 and then declined to undetectable levels by embryonic day 16 (Fig. 3D) . Collectively, these data demonstrate that neuroD3 is expressed transiently during embryogenesis, similar to the expression pattern of MATH1 (1) , and that the temporal expression of neuroD1 and neuroD2 partly overlaps that of neuroD3 but their expression persists in the adult nervous system.
To address the question of whether neuroD1 and neuroD2
were expressed in neurons in the adult mouse brain and whether they were expressed in the same cells, in situ hybridizations were performed with 35 S-UTP-labeled RNA probes. In the cerebellum, neuroD1 was easily detected in the granule layer (Fig. 4A) , whereas the neuroD2 signal was less intense in this region and was largely restricted to the region of the Purkinje cells (Fig. 4C) . In contrast, the neuroD1 and neuroD2 signal in the pyramidal cells and dentate gyrus of the hippocampus was easily detected (Fig. 4B and D) . These results demonstrate that neuroD1 and neuroD2 are expressed in neuronal populations in the mature nervous system and that their relative level of expression varies among neuronal populations.
Mouse neuroD2 and human neuroD2 induce ectopic neuronal differentiation in X. laevis. The injection of Xenopus neuroD1 RNA into X. laevis embryos resulted in the formation of ectopic neurons as well as the premature conversion of neuronal precursor cells into neurons (21) . Ectopic neurons were detected with a number of neuron-specific markers, including NCAM, a neuron-specific ␤-tubulin, and tanabin (21). To determine if neuroD2 was capable of inducing ectopic neuronal development in the frog, we injected mouse neuroD2 RNA, made from pCS2-MTmND2 (see Materials and Methods), into one side of a two-cell embryo, with the uninjected side serving as a control. As with Xenopus neuroD1, mouse neuroD2 was able to induce ectopic neuronal development, as determined by immunohistochemistry with an anti-NCAM antibody (Fig.   FIG. 2 . Alignment of mouse and human neuroD1, neuroD2, MATH2, and neuroD3 proteins. The neuroD3 sequence is based on the major ORF in the mouse and human genomic clones. ). An anti-myc tag antibody, 9E10, was used to confirm that most ectodermal cells on the injected side of the frog expressed the myc-tagged mouse neuroD2 (data not shown), and approximately 80 to 90% of injected embryos stained positively with either the anti-myc or anti-NCAM antibodies. Injection of RNA encoding the human neuroD2 gene resulted in an ectopic neuronal phenotype similar to that seen with Xenopus neuroD1 and murine neuroD2 (Fig. 5B ). This demonstrates that both neuroD1 and neuroD2 can regulate the formation of neurons and that the human and mouse neuroD2 proteins are capable of functioning in the developing Xenopus embryo. neuroD expression patterns and activity in P19 embryonic carcinoma cells. P19 cells are a well-characterized mouse embryonic carcinoma cell line with the ability to differentiate into numerous cell types, including skeletal and cardiac muscle, or neurons and glia after treatment with dimethyl sulfoxide or retinoic acid (RA) (18) , respectively. To determine whether P19 cells expressed endogenous neuroD genes during neuronal differentiation, we analyzed RNA for neuroD1, neuroD2, and neuroD3 in both uninduced and induced P19 cells. To induce the formation of neurons, P19 cells were cultured as aggregates in petri dishes in the presence of RA for 4 days. The aggregates were then plated into tissue culture dishes in the absence of RA, and neuronal differentiation occurred during a 5-day period, as evidenced by the formation of neurofilament-positive process-bearing cells (data not shown). neuroD1 mRNA was most abundant after the cells were aggregated and treated with RA for 4 days (Fig. 6, lane 6 ) and continued to be expressed at decreased levels during the period of neuronal differentiation. neuroD2 was not detected during the period of RA induction, but became abundant during the period of neuronal differentiation (Fig. 6, lane 8) . Both neuroD1 and neuroD2 signals were modestly enhanced when the differentiated P19 cultures were grown in the presence of AraC, which eliminates some of the nonneuronal dividing cells (Fig. 6, lane 9) , suggesting that the neuroD1 and neuroD2 genes are preferentially expressed in the postmitotic cell population, but further experiments will be necessary to prove this point. neuroD3 was first detected after 2 days of induction (Fig. 6, lane 4) and was most abundant after 4 days of induction (Fig. 6, lane 6) ; however, unlike neuroD1, VOL. 16, 1996 DIFFERENTIAL ACTIVITIES OF NEUROGENIC bHLH PROTEINS 5795 neuroD3 mRNA was not detected at the later, more differentiated time points. Therefore, the temporal expression pattern of neuroD1, neuroD2, and neuroD3 in differentiating P19 cells was similar to that seen during embryonic development: a peak of neuroD3 expression at the time of neuronal commitment and early neurogenesis, early and persistent expression of neuroD1, and slightly later and persistent expression of neuroD2. At this time, we have not determined whether neuroD1 and neuroD2 are expressed in the same differentiated P19 neurons. neuroD1 and neuroD2 are both expressed in neurons, and both can induce neurogenesis when expressed in frog embryos. To determine if they have the ability to activate similar target genes, we constructed expression vectors driving the human neuroD1 or neuroD2 coding regions from a simian cytomegalovirus promoter, pCS2-hND1 and pCS2-hND2, and assayed the activity of neuroD1 and neuroD2 on reporter constructs cotransfected into P19 cells. Other members of the neuroD family have been shown to bind consensus E-box sequences in vitro. Gel shift assays have demonstrated that MATH-1 and NEX-1/MATH-2 bind the consensus E-box site CAGGTG as a heterodimer with the E47 protein and activate the transcription of reporter constructs (1, 6, 30) . In vitro gel shift assays demonstrated that neuroD1 and neuroD2 can bind to an oligonucleotide containing the core E-box CACCTG as a heterodimer with an E-protein (27a). Therefore, we tested the ability of neuroD1 and neuroD2 to activate transcription of a simple reporter construct composed of a multimerized E-box with the same core sequence and the minimal promoter from the thymidine kinase gene driving the luciferase gene, p4RTK-luc. Transfection of either pCS2-hND1 or pCS2-hND2 modestly increased the level of activity from p4RTK-luc in P19 cells, increasing the activity between two-and fourfold (Fig.  7B) .
Additional reporter constructs were tested in P19 cells to determine whether neuroD1 and neuroD2 had different transcriptional activation potentials. We tested the ability of pCS2-hND1 and pCS2-hND2 to transactivate a luciferase reporter construct driven by a 760-bp core promoter of the GAP-43 gene (pGAP43-luciferase), a neuron-specific promoter construct which is upregulated in vivo in postmitotic, terminally differentiating neurons (26) . In contrast to the simple E-boxdriven reporter, pCS2-hND1 did not show significant transactivation of the pGAP43-luciferase, while pCS2-hND2 induced expression from this construct by approximately fourfold over the basal activity (Fig. 7C) .
The myogenic bHLH proteins show auto-and cross-regulation, and expression of NEX-1/MATH-2 has been shown to activate a reporter driven by the NEX-1/MATH-2 promoter (6). To determine if neuroD1 or neuroD2 could activate a construct containing the neuroD2 promoter, we made a construct that contained a 1-kb fragment upstream of the mouse neuroD2 gene, terminating in the first exon, driving the luciferase reporter gene. P19 cells were cotransfected with this pND2-luc reporter construct and the neuroD expression vectors. Both pCS2-hND1 and pCS2-hND2 transactivated this reporter construct (Fig. 7D) , suggesting that neuroD2 may be Together these transfection experiments demonstrate that neuroD1 and neuroD2 can both activate some target genes, such as a multimerized E-box reporter and the neuroD2 promoter, whereas the reporter construct driven by the GAP43 promoter seems to be preferentially activated by neuroD2. At this time, we cannot quantitate the amount of protein made from each vector after transfection, and our interpretations rely on the relative activity of the reporter constructs. Further analysis of the specificity of neuroD1 and neuroD2 will require identifying specific cis-acting sequences in these reporters that mediate activity.
DISCUSSION
We have isolated two novel genes, neuroD2 and neuroD3, that share a high degree of amino acid sequence similarity to neuroD/Beta2 (21, 25) and NEX-1/MATH2 (6, 30) . In this report we have referred to the original neuroD/Beta2 clone as neuroD1. The amino acid sequence similarity within the bHLH domain between neuroD1, neuroD2, and NEX-1/MATH-2 is greater than 90%, suggesting the possibility of a conserved function for this subfamily of bHLH genes. In addition, like NEX-1/MATH-2 and neuroD1, we have determined that the coding sequence of neuroD2 is contained in a single second exon. This is similar to the Drosophila atonal gene structure (17) , indicating that the gene structure is also conserved within this subfamily. Outside of the bHLH region of neuroD1, neu- VOL. 16, 1996 DIFFERENTIAL ACTIVITIES OF NEUROGENIC bHLH PROTEINS 5797
on February 23, 2013 by PENN STATE UNIV http://mcb.asm.org/ roD2, and NEX-1/MATH-2, there are numerous domains with significant sequence similarity. All three genes contain an amino-terminal domain rich in glutamate residues, which may represent an acidic region indicative of a transcriptional activation domain. Immediately carboxy terminal to the HLH region lies a stretch of approximately 30 amino acids which is highly conserved (over 80% sequence similarity among these three family members) that has a leucine repeat periodically interrupted by proline residues. Although the overall sequence similarity in the remainder of the carboxy-terminal region of these proteins is only 60%, there are scattered regions showing sequence conservation, and potentially these conserved motifs represent important regulatory regions of the proteins. The predicted amino acid sequence of mouse and human neuroD3 genes is based on the major ORF in the genomic DNA, since cDNAs have not been cloned for these genes. The difficulty in obtaining neuroD3 cDNA may be secondary to instability of the construct in the library, since deletions in the genomic DNA were common during amplification. The entire coding region of other neuroD family members is contained within a single exon, and therefore it is possible that the ORF in the neuroD3 genomic DNA represents the entire coding region, a notion supported by the conservation between mouse and human sequences that extends to the stop codon. The major ORF predicts a smaller protein than related neuroD family members, and lacks the glutamate-rich amino-terminal region. The bHLH region has some elements of the loop that are similar to MATH1, but the overall level of homology in the bHLH region is closer to the neuroD-related genes.
Developmental expression patterns suggest two distinct subfamilies of neurogenic bHLH genes. MATH1 and neuroD3 share similarity in the bHLH region and have similar temporal expression patterns, with RNA expression detected around embryonic day 10, but not persisting in the mature nervous system. MATH-1 RNA was localized to the dorsal neural tube in 10.5-to 11.5-day embryos, but by birth was present only in the external granule cell layer of the cerebellum, the progenitors of the cerebellar granule cell layer (1) . In contrast, the neuroD1, neuroD2, and MATH2/NEX-1 genes are expressed in both differentiating and mature neurons. Our Northern analysis demonstrates that neuroD2 expression begins around embryonic day 11 and continues through day 16, the latest embryonic time point tested. neuroD2 is detected in the brain of neonates as well as adult mice, with relatively equal abundance in both the cerebellum and cortex. Similar to neuroD2, the central nervous system expression of neuroD1 persists postnatally, as well as showing expression in the beta cells of the pancreas (25) . Northern blot analysis results presented in this paper indicate that neuroD1 expression in the adult mouse brain is most abundant in the cerebellum, with lower levels in the cerebral cortex and brain stem. NEX-1/MATH-2 gene expression is reported to occur by embryonic day 11.5, and at embryonic day 15.5, its expression is limited to the intermediate zone adjacent to the mitotically active ventricular zone, suggesting that NEX-1/MATH2 is expressed primarily in the newly differentiating neurons at this stage (6, 30) . In mature brain tissue, NEX-1/MATH-2 is expressed in neurons composing the hippocampus, subsets of cortical neurons, and postmigratory cerebellar granule cells, but the reports disagree on whether this gene is expressed in the dentate gyrus of the hippocampus. It is interesting to note that Northern analysis of MATH2 expression reported by Shimizu et al. (30) shows high levels in the cerebral cortex and low levels in the cerebellum, the opposite of the expression pattern that we see for neuroD1, suggesting that these genes may also have significant differences in relative abundance in specific regions of the nervous system. Therefore, it appears that MATH-1 and neuroD3 are expressed early in nervous system development and may have a role in either determining or expanding a population of neuronal precursors, whereas the persistent expression of neuroD1, neuroD2, and NEX-1/MATH-2 suggests a role in initiating and maintaining expression of genes related to neuronal differentiation. While this paper was in preparation, Kume et al. (20) reported the cloning of an HLH gene from rat brain tissue by a strategy designed to identify genes that are expressed during tetanic stimulation of hippocampal neurons in a model of long-term potentiation. The gene they describe, KW8, is the rat homolog of the mouse and human neuroD2 gene that we describe in this report. They also describe expression in the adult brain, including the hippocampus. Subsequently, while this paper was in review, Yasunami et al. (41) reported the mouse NDRF gene, which is nearly identical to what we have cloned as neuroD2 and demonstrated a similar expression pattern in adult brain tissue by in situ hybridization.
While expression of either neuroD1 or neuroD2 in X. laevis embryos resulted in ectopic neuronal development, it is interesting to note that neither neuroD1 nor neuroD2 was capable of converting all cell types in which it was present into neurons. As in the case of neuroD1, the ectopic neurons induced by neuroD2 were confined to a subpopulation of ectodermal cells, as shown by the spotty NCAM-positive staining pattern. The apparent restricted activity of the neuroD proteins to a subset of cells derived from the ectoderm suggests that other factors may regulate their activity, such as the notch pathway that mediates lateral inhibition during Drosophila neurogenesis.
While the induction of ectopic neurogenesis by both neuroD1 and neuroD2 in Xenopus embryos suggests a similar function, the developmental expression patterns and in vitro transfection experiments indicate that the family members may serve both overlapping and distinct functions. Previous studies have demonstrated that neuroD1/Beta2 and NEX-1/MATH2 can bind the core CANNTG sequence of an E-box as a heterodimer with an E-protein and activate transcription. In the work presented here, we have shown that both neuroD1 and neuroD2 can activate a construct containing multimerized Eboxes. They also activate a construct driven by a genomic fragment from the neuroD2 gene that presumably contains regulatory regions for neuroD2, and the temporal expression pattern of neuroD1 and neuroD2 in embryogenesis and P19 differentiation suggests a model in which neuroD1 may activate neuroD2 expression during development. Most important, however, is the demonstration that neuroD1 and neuroD2 have different capacities to activate a construct driven by the core regulatory sequences of the GAP-43 gene, demonstrating that the highly related neuroD1 and neuroD2 are capable of regulating specific subsets of genes. This promoter contains several E-boxes, and it remains to be determined if neuroD2 directly binds to these sites.
In the bHLH region, neuroD1 and neuroD2 differ by only two amino acids, and it would be anticipated that they recognize the same core binding sequences. Therefore, the differential regulation of transcriptional activity may be determined independently of DNA binding. The amino acid following the histidine in the junction region (at position "o" in Fig. 1 ) of the basic region is a glycine in neuroD1, NEX-1/MATH2, and MATH1; an aspartate in neuroD2; and an asparagine in neuroD3. This residue is positioned at the same site as the lysine residue in the myogenic bHLH proteins that has been shown to be one of the sites critical for myogenic activity (12, 13, 40) . In this case, it has been postulated to be a site of potential interaction with coactivator factors that regulate transcriptional activity. If the neuroD genes have a similar mechanism of regulation, it is possible that amino acid variability in this amino acid mediates different target specificities. Alternatively, the more divergent amino-and carboxy-terminal regions could confer regulation by interaction with other activators or repressors.
The different expression patterns in the mature nervous system and the subtle differences in target genes are similar to those of myogenic bHLH proteins. In mature muscle, myoD is expressed in fast muscle fibers and the myogenin gene is expressed in slow fibers (4, 16) , and transfection studies demonstrate that sequences adjacent to the core E-box sequence can differentially regulate the ability of MyoD and myogenin to function as transcriptional activators (3), presumably by interaction of other regulatory factors with the non-bHLH regions of MyoD and myogenin. For the neuroD-related genes, the partially overlapping expression patterns and partially overlapping target genes suggest that they may act in a combinatorial fashion to directly regulate overlapping subsets of genes and thereby confer specific neuronal phenotypes. In this model, it is possible that a small family of neuroD-related transcription factors act to establish the identity of a limited number of neuronal subtypes and that local inductive events influence the generation of a higher complexity. Alternatively, it is possible that many additional members of this subfamily are yet to be identified, and they may act to directly determine specific neuronal attributes.
